meglumine has been researched along with Hepatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, XM; Ma, C; Shang, QL; Xiao, EH | 1 |
| Biermann, KK; de Man, RA; Dwarkasing, RS; El Addouli, H; Ijzermans, JN; Thomeer, MG; Willemssen, FE | 1 |
| Calcagno, C; Dyvorne, HA; Jajamovich, GH; Rusinek, H; Taouli, B | 1 |
2 trial(s) available for meglumine and Hepatitis
| Article | Year |
|---|---|
Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis.
Topics: Adult; Contrast Media; Female; Hepatitis; Humans; Image Enhancement; Injections, Intravenous; Liver; Liver Cirrhosis; Liver Function Tests; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2017 |
DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection.
Topics: Adult; Aged; Contrast Media; Female; Hepatitis; Humans; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2014 |
1 other study(ies) available for meglumine and Hepatitis
| Article | Year |
|---|---|
MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.
Topics: Adenoma, Liver Cell; Adult; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Hepatitis; Hepatocytes; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2014 |